Additional Guidance on CY 2017 Formulary-Level Cumulative Morphine Equivalent Dose (MED) Opioid Point-of-Sale (POS) Edit
Guidance for real-time safety alerts at the time of dispensing are a prospective step to help ensure providers are aware that potentially high-risk levels of opioids will be dispensed to their patients and to promote care coordination. , CMS notified Part D sponsors of the expectation to implement either soft and/or hard formulary-level cumulative opioid edits at point-of-sale based on morphine equivalent dose to prevent potentially unsafe opioid dosing.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: July 07, 2017
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.